Diamedica Therapeutics (DMAC) Ownership - Who Owns Diamedica Therapeutics?

Q: What percentage of Diamedica Therapeutics (DMAC) stock is held by retail investors?

According to the latest TipRanks data, approximately 50.41% of Diamedica Therapeutics (DMAC) stock is held by retail investors.

Q: Who owns the most shares of Diamedica Therapeutics (DMAC)?

JAN STAHLBERG owns the most shares of Diamedica Therapeutics (DMAC).

Q: What is the significance of the ownership structure for a publicly traded company?

The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.

572 Followers

Diamedica Therapeutics (DMAC) Ownership Overview

43.45% Insiders

2.81% Mutual Funds

3.33% ETFs

50.41% Public Companies and

Individual Investors

The ownership structure of Diamedica Therapeutics (DMAC) stock is a mix of institutional, retail, and individual investors. , 43.45% is owned by Insiders, and 50.41% is owned by Public Companies and Individual Investors.

The ownership structure of Diamedica Therapeutics (DMAC) stock is a mix of institutional, retail, and individual investors. Approximately 6.14% of the company’s stock is owned by Institutional Investors, 43.45% is owned by Insiders, and 50.41% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date	Name	Activity	Value
Dec 08, 2025	Jan Stahlberg	xxxxxxxxxxxxx	$7624976
Sep 04, 2025	Jan Stahlberg	xxxxxxxxxxxxx	$5951087
Jul 25, 2025	Jan Stahlberg	xxxxxxxxxxxxx	$5400000
Jul 25, 2025	Richard Ii Jacinto	xxxxxxxxxxxxx	$1400000

Show More Insider Trading Activity >

Top Shareholders

# of Shares	Type	% Holding	Value
8,825,742	Insider	16.38%	50,483,244
8,383,577	Insider	15.56%	47,954,060
4,958,823	Insider	9.20%	28,364,468
1,159,510	Institution	2.15%	6,632,397
536,915	Institution	1.00%	3,071,154
527,114	Insider	0.98%	3,015,092
445,230	Insider	0.83%	2,546,716
354,831	Institution	0.66%	2,029,633
322,869	Institution	0.60%	1,846,811
303,940	Institution	0.56%	1,738,537

Top Mutual Fund Holders

# of Shares	Type	% Holding	Value
354,831	Institution	0.66%	2,029,633
322,869	Institution	0.60%	1,846,811
303,940	Institution	0.56%	1,738,537
201,543	Institution	0.37%	1,152,826
96,880	Institution	0.18%	554,154
92,730	Institution	0.17%	530,416
40,668	Institution	0.08%	232,621
14,680	Institution	0.03%	83,970
14,276	Institution	0.03%	81,659
13,330	Institution	0.02%	76,248

Top ETF Holders

Holder	# of Shares	Type	% Holding	Value
iShares Russell 2000 ETF	789,654	Institution	1.47%	4,990,613
Vanguard Extended Market ETF	333,456	Institution	0.62%	2,257,497
iShares Russell 2000 Growth ETF	281,737	Institution	0.52%	1,780,578
Vanguard Russell 2000 ETF	169,551	Institution	0.31%	1,147,860
iShares Micro-Cap ETF	88,119	Institution	0.16%	556,912
Vanguard Russell 2000 Growth ETF	31,501	Institution	0.06%	213,262
Global X Russell 2000 ETF	14,970	Institution	0.03%	96,557
Invesco Russell 2000 UCITS ETF	3,243	Institution	<0.01%	20,919
Vanguard Russell 3000 ETF	2,407	Institution	<0.01%	16,295
ProShares Russell 2000 High Income ETF	1,591	Institution	<0.01%	10,055

FAQ

Who Owns Diamedica Therapeutics (DMAC)?

Currently, no data Available

What percentage of Diamedica Therapeutics (DMAC) stock is held by institutional investors?

Currently, no data Available

What percentage of Diamedica Therapeutics (DMAC) stock is held by retail investors?

According to the latest TipRanks data, approximately 50.41% of Diamedica Therapeutics (DMAC) stock is held by retail investors.

Who owns the most shares of Diamedica Therapeutics (DMAC)?

JAN STAHLBERG owns the most shares of Diamedica Therapeutics (DMAC).

What is the significance of the ownership structure for a publicly traded company?

The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.